Team:LZU-China/acknowledgement

           Lanzhou University has been the best university in the northwestern region of China, ranking as one of the top 30 among over 1,500 universities across China. It is one of the key universities administered directly by the Ministry of Education.

          The School of Life Sciences at Lanzhou University has a long history. It originated as the Department of Botany and the Department of Zoology of National Lanzhou University, which were founded in 1946 as the first departments of life sciences in western China. After several generations' efforts in over sixty years, the School of Life Science is in a good development trend in many aspects, such as faculty and staff, discipline construction, teaching and researching, and local service. Basing its scientific research on the cold and arid environment in western China, the faculty has made great achievements. The School of Life Sciences is active in international collaboration in order to create an open and supportive academic atmosphere, extend academic horizons, and improve the faculty and students' ability in research and creativity.

            Cuiying Honors College (CHC) was founded in August 2010 within Lanzhou University as part of China's Top-Notch Undergraduate Training Program. The Ministry of Education and the Ministry of Finance are investing in this new pilot scheme in order to develop future leaders with exceptional talent in the core disciplines. Every year this program only admits the best 1000 students from the 6 million new undergraduates nationwide. Lanzhou University has been selected as one of 19 institutions implementing this national program.

           Takara Biotechnology (Dalian) Co., Ltd. (Takara Dalian), located in Dalian Economic and Technical Development Zone, is a subsidiary of Takara Bio Inc.(TBI), the leading Japanese manufacturer of reagents for use in genetic engineering research. Takara Bio Inc.’s products are much in demand around the world. 

           Majorbio(Shanghai) Co., Ltd. is a company focusing on the high-throughput sequencing technology, bioinformatics analysis, and clinical diagnostic kits development. So far Majorbio has build three experiment bases in Shanghai, Beijing and Guangzhou.